Background and Purpose-A number of scores were developed to predict outcomes after clipping for subarachnoid
endovascular treatment is not well characterized. Therefore, a risk score specifically for patients with SAH receiving coiling that can be easily used in clinical practice is needed.
We hypothesized that a score combining clinical, radiological, and/or biological characteristics at admission would better predict 1-year outcomes in patients with coiled SAH than the previous scores designed for patients with clipped SAH. Thus, we sought to develop an admission score in a large prospective cohort study of patients with coiled SAH, compare it with the previous scores, and validate the new score in a second cohort.
Materials and Methods

Patients
We screened 752 and enrolled 526 consecutive adult patients who were admitted from January 1, 2003, to December 31, 2009 , to the neurosurgical intensive care unit after a clinical diagnosis of SAH ( Figure 1 ). Aneurysm SAH was angiographically confirmed and coiled with or without stents. Patients whose treating physician decided to either forego any invasive treatment (nϭ48) or perform open surgical clipping (nϭ168) were excluded. Open surgery was proposed when the anatomic structure of the aneurysm increased the risk of the coiling procedure or if a parenchymatous hematoma was present with a significant mass effect at admission. Ten of the 536 patients with coiled SAH were excluded for missing values. The 526 cases were chronologically split in the derivation cohort (nϭ368, [2003] [2004] [2005] [2006] [2007] and the validation cohort (nϭ158, 2008 -2009 ). The study was approved by the local Ethics Committee in accordance with the Declaration of Helsinki and registered with ClinicalTrials.gov.
Admission Characteristics
We recorded the following clinical characteristics: age, sex, GCS, presence of motor deficit, presence of clinical seizure, and WFNS score (online-only Supplemental Table I , http://stroke.ahajournals. org). 9 The GCS refers to the value at admission before any treatment with sedative drugs or treatment of hydrocephalus. We also recorded biological characteristics with routine sampling of S100␤ and troponin at admission (online-only Supplemental Methods). Admission S100␤ and troponin I levels were considered high for values Ͼ0.5 g/L (corresponding to 5 times the maximum normal range) to be consistent with previous studies. 13, 17 Admission radiological characteristics were obtained from the admission CT scan, including hydrocephalus and intraventricular hemorrhage, and the initial angiogram, including aneurysm localization and lateral size. The CT scan was classified according to the modified Fisher score (online-only Supplemental Table II) by a neuroradiologist blinded to the patient's biomarker data. 11
Intensive Care Unit Management
All patients with SAH were followed in the intensive care unit (for more detail, see online-only Supplemental Methods). Early (coiling complication, intraventricular hemorrhage, intracranial hypertension, hydrocephalus) and delayed (vasospasm) cerebral lesions were recorded.
Clinical Outcome
The primary outcome, 1-year mortality, was systematically assessed using the Rankin outcome scale (online-only Supplemental Table III) at 1 year after intensive care unit discharge. 19, 20 The GCS, WFNS, and Fisher scores were compared to the admission bioclinical score (ABC score) for the prediction of 1-year mortality (Rankin 6), 1-year independent function (Rankin 0 -3), and 1-year full recovery .
Sensitivity analysis of the 1-year mortality outcomes was conducted by dividing the derivation cohort into 2 groups based on their coma status (coma: GCS Ͻ13 [WFNS 4 or 5] versus noncoma: GCS Ն13 [WFNS 1-3]).
Statistical Analysis
To identify factors that were independently associated with 1-year mortality, multivariate models were evaluated using forward and backward stepwise logistic regression for: age, gender, seizure, GCS, Fisher score, intraventricular hemorrhage, hydrocephalus, high troponin I, and high S100␤. The weights of the ABC score components were derived from the ORs of the most parsimonious model. We assessed calibration of the ABC score with the Hosmer-Lemeshow goodness-of-fit test.
We constructed receiver operating characteristic (ROC) curves and compared the areas under the ROC curves (AUC-ROC) of the ABC, WFNS, GCS, and Fisher scores to predict 1-year mortality, 1-year independent function (Rankin score 0 -3), and 1-year full recovery (Rankin score 0 -1). The integrated discrimination improvement, the net reclassification improvement, and risk stratification capacity were performed to compare the 4 scores for each end point (online-only Supplemental Methods). [21] [22] [23] Sensitivity analyses of the AUC-ROC regarding coma status and early and delayed cerebral lesions were performed in the derivation cohort.
Data are expressed as a percentage (with 95% CIs) for binary variables, median (interquartiles) for discontinuous variables, and as a meanϮSD for continuous variables. All tests are 2-sided and all probability values are provided uncorrected. Probability values Ͻ0.05 were considered significant. Statistical analyses were performed using STATA Version 11 (StataCorp).
Results
The 1-year mortality of the 526 cases was 17.7% (95% CI, 14.4%-21.0%; Figure 1 ). Derivation and validation cohorts were similar in all main admission characteristics (Table 1) . Furthermore, across the 7 years of the study, the proportions of 1-year mortality and 1-year full recovery were similar (Pϭ0.92 and Pϭ0.57, respectively) with no difference between the derivation and validation cohorts (Table 1) .
ABC Score Development
Univariate analysis for 1-year mortality showed that age, gender, seizure, GCS, WFNS, troponin I, S100␤, Fisher score, hydrocephalus, and intraventricular hemorrhage were associated with 1-year mortality ( Table 2 ). In contrast, motor deficit without any consciousness deterioration (WFNS 3, Pϭ0.66), aneurysmal localization (Pϭ0.52), and lateral size (Pϭ0.63) were not associated with 1-year mortality. The causes of both early and delayed cerebral lesions were associated with 1-year mortality (Table 2 ). Multivariate logistic regression followed by stepwise forward and backward stepwise analysis determined that only the GCS (PϽ0.001), high S100␤ (PϽ0.001), and high troponin I (Pϭ0.02) were independently associated with 1-year mortality (Table 3) . A simplified ABC score was constructed taking into account the ORs of the most parsimonious model. The ABC score combines the GCS and the admission troponin and S100␤ values into a single value between 0 and 6 ( 
ABC Score Comparison
Comparisons of the ROC-AUCs showed that the GCS (0.79; 0.74 -0.85) and WFNS scores (0.79; 0.73-0.84) were more powerful than the Fisher score (0.69; 0.62-0.76) for predicting 1-year mortality (Pϭ0.002 and Pϭ0.003, respectively).
The ROC-AUC of the ABC score was superior to the ROC-AUCs of the WFNS (Pϭ0.001), GCS (Pϭ0.03), and Fisher scores (PϽ0.001) for predicting 1-year mortality in the overall population ( Figure 2A ). The integrated discrimination improvement showed that the ABC score was superior to the 3 other scores (PϽ0.001; online-only Supplemental Figure I ). The net reclassification improvement was statistically higher for the ABC score than for the 3 other scores with 2 different thresholds (PϽ0.05 for each comparison; online-only Supplemental Table IV ). The risk stratification capacity was also superior for the ABC score (PϽ0.001). Moreover, in the coma subgroup, the ABC score was a significant predictor of 1-year mortality (0.70; 0.60 -0.80, PϽ0.001) and superior to the WFNS (Pϭ0.01), GCS (Pϭ0.01), and Fisher scores (Pϭ0.002; online-only Supplemental Figure II ). With regard to the prediction of 1-year full recovery (Rankin 0 -1), the ABC score's ROC-AUC of 0.83 (0.79 -0.88) was greater than the ROC-AUC of the WFNS (Pϭ0.004), GCS (Pϭ0.007), and Fisher scores (PϽ0.001). Concerning 1-year independent function (Rankin 0 -3), the ABC score's ROC-AUC was also greater than the ROC-AUC of the 3 other scores (online-only Supplemental Table V) . Sensitivity analyses of the ABC score for early and delayed cerebral lesions showed that the ROC-AUC values for predicting 1-year mortality were statistically superior to the reference line (PϽ0.01 for each comparison; online-only Supplemental Table VI) . Moreover, the ABC score presents a practical value with a greater range of probability than the 3 other scores to predict 1-year mortality, independent function, and full recovery (Table 4 ; Figure 2C -D).
ABC Score Validation
In the validation cohort (Table 1) , the discriminative power of the ABC score to predict 1-year mortality was statistically significant (0.76; 0.67-0.86, PϽ0.001). The ROC-AUC of the ABC score was superior to the ROC-AUC of the WFNS (Pϭ0.01), GCS (Pϭ0.002), and Fisher scores (Pϭ0.03) for predicting 1-year mortality ( Figure 2B ) and 1-year independent function (Rankin 0 -3; online-only Supplemental Table VI) .
Discussion
The goal of our prospective study was to develop, compare, and validate a better admission score for predicting 1-year outcomes in patients with coiled SAH. This led to the ABC score, which combines clinical and biological measurements and which was superior to the 3 pre-existing scores for predicting 1-year outcomes in a validation cohort.
Usefulness of a Simplified Admission Score for Coiled SAH
Patients with SAH have a heterogeneous presentation at admission. Thus, an accurate predictive score is necessary for identifying the patient's risk of mortality and for tailoring therapy to the individual patient. In addition to assisting physicians, admission scores help patients and their relatives. 24 Admission scores are also important in Phase III trials for discriminating among subpopulations. 25 As a result of the International Subarachnoid Aneurysm Trial (ISAT), 4 many neurosurgeons and neuroradiologists have decided to treat patients with SAH with coiling. However, we found no accurate score for predicting long-term outcomes in coiled patients. 26 -29 All admission characteristics that were statistically associated with 1-y mortality were included in the multivariate analysis. World Federation of Neurological Surgeons was excluded from the analysis because of colinearity with the GCS (Spearman test, ϭϪ0.987, PϽ0.0001). The last 5 columns represent the backward stepwise logistic regression using the parameter of PϽ0.2 and showing P values at each step after the highest value was dropped.
GCS indicates Glasgow Coma Scale; High troponin I and high S100␤ correspond to values Ͼ0.5 g/L at admission.
Relevance of ABC Score Components
In this study, we decided to compare the main clinical, biological, and radiological factors already known to be associated with long-term outcomes to generate a new score specifically dedicated to coiled SAH. We first observed in our derivation cohort that the 3 pre-existing scores had no discriminating power in the coma group (PϾ0.24 for each comparison). The GCS was strongly associated with 1-year mortality, although only for GCS values Ն13. Therefore, we decided to give all GCS values Ͻ13 the same weight in the ABC score. Troponin I and S100␤ levels were also strongly associated with 1-year mortality. Cardiovascular biological markers like troponin I have been associated with mortality in SAH cases. 12, 30, 31 Although the causes of cardiac abnormalities after SAH cases are controversial, experimental data indicate that catecholamine toxicity plays a key role. [32] [33] [34] Although the causal links and associations between cardiac abnormalities and SAH outcomes are not clearly understood, troponin I is useful for predicting outcomes because of its association with primary brain injury and cardiac dysfunction. S100␤ increases with traumatic or vascular damage to brain tissue. Thus, high plasma S100␤ concentration is common after SAH and has been shown to predict death and other unfavorable outcomes. 16, 35, 36 Interestingly, age was associated with 1-year mortality in the univariate but not the stepwise multivariate analyses. Elderly patients' vulnerability to poor cardiac and consciousness outcomes could explain why our 3 predictors aggregate most of the age effects to predict 1-year mortality. Thus, we confirmed a posteriori that the addition of age as a variable did not statistically improve the ABC score's prediction of 1-year mortality. Furthermore, we tested different combinations (eg, ageϩGCSϩtroponin, ageϩGCSϩS100, ageϩGCS), and the AUC-ROCs were always less than the AUC-ROC of the ABC score (PϽ0.04 for the 3 comparisons, not shown).
Study Strengths and Limitations
It may be difficult to assess comorbidities like chronic hypertension and smoking history right at admission. Therefore, only data that were readily accessible in clinical practice at admission were studied.
We decided to construct a simplified predictive score with the fewest criteria to facilitate its use at patient admission in standard clinical practice. To simplify the risk score, the troponin I and S100␤ values were dichotomized. However, because the choice of threshold could affect the score's discriminating power, we reconstructed our risk score in the derivation cohort using different combinations of thresholds for troponin I and S100␤, ranging from 0.25 to 1 g/L without finding any significant AUC-ROC difference (PϾ0.05, data not shown). Furthermore, we stratified troponin I and S100␤ into 3-level variables (low for values Ͻ0.25 g/L, intermediary, and high for values Ͼ1 g/L), rebuilt our risk score with different combinations of 2-level or 3-level variables, and did not find any AUC-ROC differences between our original score and these newly created scores (PϾ0.05).
When comparing the ABC score with pre-existing scores, we decided to use the statistical methods that could identify the specific advantages of adding new predictors. 21 These methods would address discrimination (change in ROC-AUC and integrated discrimination improvement) as well as reclassification (net reclassification improvement and risk stratification capacity). The sensitivity analyses for each of the major complications showed that the ABC score had also the power to predict 1-year mortality for each subgroup (onlineonly Supplemental Table VI) .
A limitation of this study is that it was monocentric, because survival may be dependent on intensive care unit management. However, the advantage of our study was that all patients were managed in highly standardized conditions 36, 37 that allowed us to identify clinically relevant independent risk factors. Nevertheless, a prospective and multicenter study featuring different intensive care unit therapeutic strategies should be conducted to confirm the value of this improved score.
Conclusions
This is the first study to provide large cohort-based evidence supporting the integration of biomarkers and clinical characteristics for the prediction of 1-year outcomes in patients with SAH receiving aneurysm coiling. The simplified ABC score was superior to the GCS, WFNS, and Fisher scores for 
The ABC score is the sum of the points corresponding to each component (score ranges from 0 to 6). The ABC score's calibration was adapted (Pϭ0.1, goodness-of-fit test).
GCS indicates Glasgow Coma Scale. High troponin I and high S100␤ correspond to values Ͼ0.5 g/L at admission.
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predicting 1-year mortality in an independent validation cohort. However, additional studies are needed to confirm these results at other centers. 
Biological Sampling Methods
Admission biological sampling of venous blood was routinely performed to measure S100β and troponin I per standard clinical practice. S100β concentrations were measured using an immunoluminometric sandwich assay on a LIA-mat 300 analyzer (Byk-Sangtec France Laboratories, France) and troponin I was measured with the Troponin Ic assay (Stratus Analyzer by Dade, France). S100β and troponin I levels were considered high for values greater than 0.5 µg/L (corresponding to 5 times the maximum normal range).
ICU Management
Patients with CT-scan evidence of hydrocephalus, WFNS score between III and V, or a transcranial Doppler (TCD) pulsatility index greater than 1.4 received an external ventricular drain (EVD) before coiling. All patients received total intravenous (IV) anesthesia to prevent movement during coiling. Coiling complications were recorded throughout the procedure. After the intervention, systolic arterial blood pressure was maintained between 130 and 150 mmHg by a titration of IV norepinephrine. Intracranial hypertension was treated using cerebro-spinal fluid drainage, deepening of sedation and, rarely, moderate hypothermia.
We used a previously reported strategy for cerebral vasospasm management. 1 Briefly, all patients received IV nimodipine from admission until the end of the second week after admission. TCD was performed at least once a day during the first 10 days. In the event of clinical deterioration or an increase in mean TCD velocities or S100β, a cerebral angiogram was performed after CT-scan ruled out other complications. Vasospasm episodes were treated using intra-arterial nimodipine administration, repeated if necessary and rarely combined with intraarterial milrinone. 
Statistical Analysis
The integrated discrimination improvement (IDI) 3, 4 comparing the delta of the predicted probabilities of 1-year mortality in the deceased and alive groups was calculated for the ABC score and the 3 other scores. Cross-tabulations of risk categories based on the ABC and the 3 other scores were performed to describe the number of cases that were reclassified appropriately according to the mortality risk. Two different thresholds of mortality prediction were used (10% and 33%) to discriminate between low and high risk. We calculated the net reclassification improvement (NRI) with these 2 thresholds 3, 4 and the continuous NRI without thresholds 5 to compare the ABC to the 3 other scores. According to this method, calculating the continuous NRI without respect to thresholds provides a more objective and versatile measure of improvement in risk prediction when established risk categories do not exist. Here, one counts the number of times the predicted probability using one model exceeds another and vice versa by event status (e.g., deceased or alive at 1-year). We derived bootstrap 95% confidence intervals for the NRI using 1000 replications. With this method we found that the continuous NRI for the ABC score compared to the 3 other scores was always significantly greater than 0.
The risk stratification capacity 3, 4 comparing the proportion of cases that are classified in the intermediate risk ([number of deaths classified between the low and high thresholds + number of living patients classified between the low and high thresholds]/total number of cases) in different models was performed with the same thresholds (10% and 33%). 
Supplemental
Supplemental Figures
Supplemental Figure S1 The black bars correspond to the predicted probability of 1-year mortality in the 1-year deceased population and the white bars correspond to the predicted probability of 1-year mortality in the 1-year living population. The delta (∆) is the difference between the black and white bars. The 1-year mortality integrated discrimination improvement, corresponding to the comparison of the ∆s, showed that the ABC score was superior to the 3 other scores for correctly discriminating between the patient's 1-year outcome (P<0.001). ABC: Admission Bio-Clinical, GCS: Glasgow Coma Scale, WFNS: World Federation of Neurological Surgeons, ∆: difference between the predicted probability of mortality in the 1-year deceased cases and the 1-year living cases, ***:P<0.001. 
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